Keyur P. Vora

@KeyurVoraMD

Cardiologist & Innovator: PASSION = CMRCTEcho STEMI Trials. “Prescribing the Future by Today’s Research” 🇮🇳🇺🇸

Indiana, USA Joined May 2020

85 Following 74 Followers 68 Posts

Latest posts 5

Pinned post

Keyur P. Vora @KeyurVoraMD Aug 27, 2025

“MIRON-TROP Clinical Trial in “New England Journal of Medicine - Evidence”

evidence.nejm.org/doi/full/10.10…

First Ever: Troponin is no longer just a marker of any MI — Post-PCI Troponin is a precision diagnostic method to identify Hemorrhagic MI.
@rohandkumar1 @IUMedSchool @IURadiology

0:56

Keyur P. Vora @KeyurVoraMD Sep 29

Great to be at Indiana-ACC meeting with Dr Ed Fry, Past ACC President and co-author of our SHIELD MI Trial. Latest Topics and Great Conversations!!!
academic.oup.com/eurheartj/adva…

Keyur P. Vora @KeyurVoraMD Sep 10

Proud to present SHIELD-MI at ESC Congress 2026, Munich Germany - exploring a new peri-PCI strategy to target intramyocardial hemorrhage, limit infarct expansion, and preserve LV function after STEMI !!!

In STEMI, restoring epicardial flow is only the first step. Intramyocardial hemorrhage drives infarct expansion, and worse outcomes. SHIELD-MI evaluated peri-PCI dexrazoxane as a strategy to target IMH in acute stage.

Keyur P. Vora @KeyurVoraMD Feb 17

It was an excellent clinical conference at the SCMR 29th Annual Scientific Sessions at Rio de Janeiro, Brazil to present our latest trials showcasing the critical role of Cardiovascular MRI in STEMI care. @IURadiology @IUMedSchool @IU_Health @rohandkumar1 @SCMR @BrunoLimaMDPhD

Keyur P. Vora @KeyurVoraMD Nov 2, 2025

MIRON-TROP trial at #TCT2025 San Francisco

Our research identifies a key driver of in-hospital mortality post-PCI: hemorrhagic myocardial infarction.

We found that post-procedural troponin kinetics can be used to diagnose this critical stage of MI

Thank you @CRFheart & @TCTMD